In this episode of "The Top Line," our Fierce reporters tackle topics like the trends we saw at Cannes Lions, the cancer drug shortage, and the top compensated CEOs in the industry.
To learn more about the topics in this episode:
- National cancer group reports widespread chemo shortages, calls on government and industry to help resolve them
- FDA to allow temporary overseas production to shore up supplies of chemo drug
- FDA can't solve drug shortages on its own, agency's oncology chief says
- Play it loud: Cannes winner pitches sound therapy as extra tool in arsenal against cancer
- How Eversana roared back from rejection to craft Cannes-winning campaign hospitals couldn't ignore
- In a year of turnover, Seagen doled out $126M to a trio of CEOs
- The 15 highest paid pharma CEOs of 2021
- UPDATED: Moderna CEO Stéphane Bancel earned $19.4M in 2022 but made much more in stock sales
"The Top Line" and "Podnosis" are produced by senior podcast producer Teresa Carey. The stories are by all our “Fierce” journalists. Like and subscribe wherever you listen to your podcasts.